Gland Pharma Ltd. (GLAND)
Market Open
19 Oct, 10:00 AM
MSE XNSE Primary MSE ₹
3,027. 25
-15.95
-0.5241%
₹
- Market Cap
- P/E Ratio
- Div Yield
259,302 Volume
- Eps
₹ 3,043.2
Previous Close Want to track GLAND and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gland Pharma Ltd. (GLAND) Statistics
Valuation metrics
Market Cap -
Enterprise value 502.19B
Trailing P/E (ttm) 44.42
Forward P/E -
PEG ratio 0.95
Price/Sales (ttm) 7.47
Price/Book (mrq) 4.84
Enterprise Value/Revenue 7.47
Enterprise Value/EBITDA 25.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 78.96K
Average volume (90 days) 250.53K
Price summary
52-Week low 1,575
52-Week high 3,171
Beta -
50-Day moving average 2,955.87
200-Day moving average 2,440.29
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 20
Trailing annual dividend yield 0.0066%
5-Year annual dividend yield -
Payout ratio 0.26
Dividend Date 24 Sep 2026
Ex-Dividend Date 11 Aug 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.17%
Operating margin 0.2%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 408.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 68.48
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 208.27
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 4.68%
Book value per share (mrq) 628.42
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
